KKR, a global investment firm, agreed to acquire a majority stake in Argenta, an animal health-focused pharma services platform, from the Tomlinson Group for $100m. “I am very pleased to welcome KKR as a valued partner to the Argenta team and to our strategy of bringing innovative animal health products to market on a global scale. Our fast-moving customers have high expectations and KKR’s investment will propel Argenta forward so we can continue to meet these expectations by bringing new capabilities and growth opportunities. At the core of Argenta is collaboration: among our team, with our customers and now with KKR. Together, we will continue to deliver the best animal health technologies and services possible,” Ben Russell, Argenta CEO.